Skip to main content

Table 1

From: TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

CRPC Genes

Forward (5′ ➔ 3′)

Reverse (5′ ➔ 3′)

UBE2C

TGGTCTGCCCTGTATGATGT

AAAAGCTGTGGGGTTTTTCC

CDK1

CCTAGTACTGCAATTCGGGAAATT

CCTGGAATCCTGCATAAGCAC

CCNA2

CAGAAAACCATTGGTCCCTC

CACTCACTGGCTTTTCATCTTC

CDC20

CCTCTGGTCTCCCCATTAC

ATGTGTGACCTTTGAGTTCAG

TMPRSS2

CAGGAGTGTACGGGAATGTGATGGT

GATTAGCCGTCTGCCCTCATTTGT

GAPDH

ATCACCATCTTCCAGGAGCGA

GCCAGTGAGCTTCCCGTTCA